During a panel discussion beginning Monday at 1:30 p.m. PT in Room 28, nephrology and diabetes experts, including Titilayo O. Ilori, MD, MSc, will discuss the impact of race, ethnicity, and underrepresentation of vulnerable populations in clinical trials in relation to diabetes and kidney disease. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Up next: Joint ADA/ASN Symposium—How Do We Address the Psychosocial Determinants of Health in Diabetes and Kidney Disease?
